Galena Biopharma, Inc. (SLS) Expected to Post Earnings of -$0.31 Per Share

Equities research analysts expect Galena Biopharma, Inc. (NYSE:SLS) to announce earnings of ($0.31) per share for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Galena Biopharma’s earnings. The business is expected to announce its next quarterly earnings report on Friday, April 12th.

According to Zacks, analysts expect that Galena Biopharma will report full-year earnings of ($2.77) per share for the current year. For the next financial year, analysts forecast that the firm will post earnings of ($0.74) per share. Zacks Investment Research’s EPS averages are a mean average based on a survey of research analysts that cover Galena Biopharma.

Shares of Galena Biopharma stock traded down $0.02 on Wednesday, hitting $1.65. The company had a trading volume of 4,466 shares, compared to its average volume of 908,767. Galena Biopharma has a twelve month low of $0.80 and a twelve month high of $12.00.

Galena Biopharma Company Profile

Develop biopharmaceuticals

Read More: What are trading strategies for the 52-week high/low?

Get a free copy of the Zacks research report on Galena Biopharma (SLS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Galena Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galena Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply